Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Intracardiac or intrapulmonary shunts were present in at least 35% of adults with homozygous sickle cell disease followed in an outpatient clinic.

Hambley BC, Abdul Rahman R, Reback M, O'Riordan MA, Langer N, Gilkeson RC, Ginwalla M, Little JA, Schilz R.

Haematologica. 2018 Jul 13. pii: haematol.2018.196212. doi: 10.3324/haematol.2018.196212. [Epub ahead of print] No abstract available.

2.

Completed FDA feasibility trial of surgically placed temporary diaphragm pacing electrodes: A promising option to prevent and treat respiratory failure.

Onders RP, Markowitz A, Ho VP, Hardacre J, Novitsky Y, Towe C, Elmo M, Kaplan C, Schilz R.

Am J Surg. 2018 Mar;215(3):518-521. doi: 10.1016/j.amjsurg.2017.10.054. Epub 2017 Nov 11.

PMID:
29195690
3.

Cardiovascular evaluation and management of iron overload cardiomyopathy in sickle cell disease.

Ginwalla M, AlMasoud A, Tofovic D, Alin T, Al-Kindi S, Oliveira G, Rajagopalan S, Schilz R, Little J.

Am J Hematol. 2018 Jan;93(1):E7-E9. doi: 10.1002/ajh.24924. Epub 2017 Oct 23. No abstract available.

PMID:
28971490
4.

Inhaled Prostacyclin as Salvage Therapy for ARDS: Can We Find the Right Patient?

Attaway AH, Myers C, Velani S, Schilz R.

Respir Care. 2017 Aug;62(8):1113-1115. doi: 10.4187/respcare.05708. No abstract available.

PMID:
28733316
5.

Right ventricle dimensions and function in response to acute hypoxia in healthy human subjects.

Netzer NC, Strohl KP, Högel J, Gatterer H, Schilz R.

Acta Physiol (Oxf). 2017 Feb;219(2):478-485. doi: 10.1111/apha.12740. Epub 2016 Jul 15.

PMID:
27332955
6.

Nocturnal hemoglobin desaturation is associated with reticulocytosis in adults with sickle cell disease and is independent of obstructive sleep apnea.

Rotz SJ, Ann O'riordan M, Kim C, Langer N, Cruz C, Schilz R, Lance C, Little JA.

Am J Hematol. 2016 Sep;91(9):E355-6. doi: 10.1002/ajh.24432. Epub 2016 Jun 20. No abstract available.

7.

Evaluation of the Solitary Pulmonary Nodule.

Kikano GE, Fabien A, Schilz R.

Am Fam Physician. 2015 Dec 15;92(12):1084-91.

8.

Phase I safety study of ranolazine in pulmonary arterial hypertension.

Gomberg-Maitland M, Schilz R, Mediratta A, Addetia K, Coslet S, Thomeas V, Gillies H, Oudiz RJ.

Pulm Circ. 2015 Dec;5(4):691-700. doi: 10.1086/683813.

9.

The Role of Echocardiography in the Evaluation of Pulmonary Arterial Hypertension.

Pristera N, Musarra R, Schilz R, Hoit BD.

Echocardiography. 2016 Jan;33(1):105-16. doi: 10.1111/echo.13113. Epub 2015 Nov 2. Review.

PMID:
26522749
10.
11.

Hospitalization and survival in patients using epoprostenol for injection in the PROSPECT observational study.

Frantz RP, Schilz RJ, Chakinala MM, Badesch DB, Frost AE, McLaughlin VV, Barst RJ, Rosenberg DM, Miller DP, Hartline BK, Benton WW, Farber HW.

Chest. 2015 Feb;147(2):484-494. doi: 10.1378/chest.14-1004.

12.

Extended use of diaphragm pacing in patients with unilateral or bilateral diaphragm dysfunction: a new therapeutic option.

Onders RP, Elmo M, Kaplan C, Katirji B, Schilz R.

Surgery. 2014 Oct;156(4):776-84. doi: 10.1016/j.surg.2014.07.021.

PMID:
25239317
13.

COPD in a nationally representative sample: sociodemographic factors and co-morbidity, diagnosis method, and healthcare utilization.

Mowls DS, Cheruvu VK, Schilz R, Zullo MD.

COPD. 2015 Feb;12(1):96-103. doi: 10.3109/15412555.2014.922065. Epub 2014 Jul 10.

PMID:
25010648
14.

Final analysis of the pilot trial of diaphragm pacing in amyotrophic lateral sclerosis with long-term follow-up: diaphragm pacing positively affects diaphragm respiration.

Onders RP, Elmo M, Kaplan C, Katirji B, Schilz R.

Am J Surg. 2014 Mar;207(3):393-7; discussion 397. doi: 10.1016/j.amjsurg.2013.08.039. Epub 2013 Dec 19.

PMID:
24439161
15.

Quality initiatives and models of care in patients with pulmonary arterial hypertension: the time has come!

Schilz R, Farber HW.

Int J Clin Pract Suppl. 2011 Dec;(174):1-3. doi: 10.1111/j.1742-1241.2011.02835.x. No abstract available.

PMID:
22171815
16.

Amyotrophic lateral sclerosis: the Midwestern surgical experience with the diaphragm pacing stimulation system shows that general anesthesia can be safely performed.

Onders RP, Carlin AM, Elmo M, Sivashankaran S, Katirji B, Schilz R.

Am J Surg. 2009 Mar;197(3):386-90. doi: 10.1016/j.amjsurg.2008.11.008.

PMID:
19245920
17.

Dose proportionality of treprostinil sodium administered by continuous subcutaneous and intravenous infusion.

McSwain CS, Benza R, Shapiro S, Hill N, Schilz R, Elliott CG, Zwicke DL, Oudiz RJ, Staszewski JP, Arneson CP, Wade M, Zaccardelli D, McLaughlin V.

J Clin Pharmacol. 2008 Jan;48(1):19-25.

18.

Transition from IV epoprostenol to subcutaneous treprostinil in pulmonary arterial hypertension: a controlled trial.

Rubenfire M, McLaughlin VV, Allen RP, Elliott G, Park MH, Wade M, Schilz R.

Chest. 2007 Sep;132(3):757-63. Epub 2007 Mar 30. Erratum in: Chest. 2007 Nov;132(5):1721.

PMID:
17400684
19.

Diaphragm pacing with natural orifice transluminal endoscopic surgery: potential for difficult-to-wean intensive care unit patients.

Onders R, McGee MF, Marks J, Chak A, Schilz R, Rosen MJ, Ignagni A, Faulx A, Elmo MJ, Schomisch S, Ponsky J.

Surg Endosc. 2007 Mar;21(3):475-9. Epub 2006 Dec 20.

PMID:
17177078
20.

Laparoscopic retroperitoneal repair of a right-sided Bochdalek hernia.

Rosen MJ, Ponsky L, Schilz R.

Hernia. 2007 Apr;11(2):185-8. Epub 2006 Nov 21.

PMID:
17119855
21.

Cost-minimization analysis of treprostinil vs. epoprostenol as an alternate to oral therapy non-responders for the treatment of pulmonary arterial hypertension.

Narine L, Hague LK, Walker JH, Vicente C, Schilz R, Desjardins O, Einarson TR, Iskedjian M.

Curr Med Res Opin. 2005 Dec;21(12):2007-16.

PMID:
16368052
22.

The 6-min walk test (6MW) as an efficacy endpoint in pulmonary arterial hypertension clinical trials: demonstration of a ceiling effect.

Frost AE, Langleben D, Oudiz R, Hill N, Horn E, McLaughlin V, Robbins IM, Shapiro S, Tapson VF, Zwicke D, DeMarco T, Schilz R, Rubenfire M, Barst RJ.

Vascul Pharmacol. 2005 Jun;43(1):36-9.

PMID:
15890561
23.

Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease.

Oudiz RJ, Schilz RJ, Barst RJ, Galié N, Rich S, Rubin LJ, Simonneau G; Treprostinil Study Group.

Chest. 2004 Aug;126(2):420-7.

PMID:
15302727
24.

The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants.

Minari A, Husni R, Avery RK, Longworth DL, DeCamp M, Bertin M, Schilz R, Smedira N, Haug MT, Mehta A, Gordon SM.

Transpl Infect Dis. 2002 Dec;4(4):195-200.

PMID:
12535262
25.

Clinical characteristics of 13 solid organ transplant recipients with ganciclovir-resistant cytomegalovirus infection.

Isada CM, Yen-Lieberman B, Lurain NS, Schilz R, Kohn D, Longworth DL, Taege AJ, Mossad SB, Maurer J, Flechner SM, Mawhorter SD, Braun W, Gordon SM, Schmitt SK, Goldman M, Long J, Haug M, Avery RK.

Transpl Infect Dis. 2002 Dec;4(4):189-94.

PMID:
12535261
26.

The prostacyclin analogue treprostinil blocks NFkappaB nuclear translocation in human alveolar macrophages.

Raychaudhuri B, Malur A, Bonfield TL, Abraham S, Schilz RJ, Farver CF, Kavuru MS, Arroliga AC, Thomassen MJ.

J Biol Chem. 2002 Sep 6;277(36):33344-8. Epub 2002 Jun 24.

27.

The humoral immune response to influenza vaccination in lung transplant patients.

Mazzone PJ, Mossad SB, Mawhorter SD, Mehta AC, Schilz RJ, Maurer JR.

Eur Respir J. 2001 Dec;18(6):971-6.

28.

Enhanced cyclosporine-itraconazole interaction with cola in lung transplant recipients.

Wimberley SL, Haug MT 3rd, Shermock KM, Qu A, Maurer JR, Mehta AC, Schilz RJ, Gordon SM.

Clin Transplant. 2001 Apr;15(2):116-22.

PMID:
11264638
29.

Hypogammaglobulinemia in lung transplant recipients.

Goldfarb NS, Avery RK, Goormastic M, Mehta AC, Schilz R, Smedira N, Pien L, Haug MT, Gordon SM, Hague LK, Dresing JM, Evans-Walker T, Maurer JR.

Transplantation. 2001 Jan 27;71(2):242-6.

PMID:
11213067
30.

Increased alveolar macrophage nuclear factor-kappa B activation and macrophage inhibitory protein-1alpha levels in lung transplant patients.

Farver CF, Raychaudhuri B, Malur A, Drazba J, Maurer J, Tubbs R, Mehta AC, Schilz R, Thomassen MJ.

Transplantation. 2000 Dec 15;70(11):1599-603.

PMID:
11152221
31.

Progressive portopulmonary hypertension after liver transplantation treated with epoprostenol.

Rafanan AL, Maurer J, Mehta AC, Schilz R.

Chest. 2000 Nov;118(5):1497-500.

PMID:
11083710
32.

Exercise hemodynamic findings in patients with exertional dyspnea.

James KB, Maurer J, Wolski K, Lutton SR, Haas G, Schilz R, Rubin D, Young JB.

Tex Heart Inst J. 2000;27(2):100-5.

33.

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.

Badesch DB, Tapson VF, McGoon MD, Brundage BH, Rubin LJ, Wigley FM, Rich S, Barst RJ, Barrett PS, Kral KM, Jöbsis MM, Loyd JE, Murali S, Frost A, Girgis R, Bourge RC, Ralph DD, Elliott CG, Hill NS, Langleben D, Schilz RJ, McLaughlin VV, Robbins IM, Groves BM, Shapiro S, Medsger TA Jr.

Ann Intern Med. 2000 Mar 21;132(6):425-34.

PMID:
10733441
34.

Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus.

Robbins IM, Gaine SP, Schilz R, Tapson VF, Rubin LJ, Loyd JE.

Chest. 2000 Jan;117(1):14-8.

PMID:
10631192
35.
36.

Intravenous azithromycin-induced ototoxicity.

Bizjak ED, Haug MT 3rd, Schilz RJ, Sarodia BD, Dresing JM.

Pharmacotherapy. 1999 Feb;19(2):245-8.

PMID:
10030778
37.

Spontaneous resolution of rhodococcal pulmonary infection in a liver transplant recipient.

Schilz RJ, Kavuru MS, Hall G, Winkelman E.

South Med J. 1997 Aug;90(8):851-4. Review.

PMID:
9258318
38.
39.

Transgenic modeling of cytokines in the investigation of pulmonary disease.

Elias JA, Geba GP, Tang W, Schilz R, Zheng T, DiCosmo B, Flavell RA.

Chest. 1996 Mar;109(3 Suppl):69S-73S. No abstract available.

PMID:
8598165

Supplemental Content

Loading ...
Support Center